Table 4.
Laboratory data (mean ± SE) | Living liver donor (n = 5) | Without chemotherapy (n = 9) | With chemotherapy (n = 8) | p value* |
---|---|---|---|---|
T-Bill (mg/dl) |
||||
Preoperative |
0.69 ± 0.05 |
0.77 ± 0.18 |
0.45 ± 0.04 |
0.03 |
5 postoperative days |
1.64 ± 0.44 |
1.42 ± 0.27 |
1.28 ± 0.27 |
0.81 |
Early period |
0.93 ± 0.20 |
0.80 ± 0.21 |
1.60 ± 1.02 |
0.61 |
Late period |
0.79 ± 0.11 |
0.72 ± 0.08 |
0.74 ± 0.08 |
0.97 |
PT-INR |
||||
Preoperative |
0.97 ± 0.02 |
0.96 ± 0.02 |
0.97 ± 0.03 |
0.82 |
5 postoperative days |
1.11 ± 0.03 |
1.12 ± 0.03 |
1.10 ± 0.04 |
0.81 |
Early period |
1.07 ± 0.05 |
1.01 ± 0.03 |
1.05 ± 0.04 |
0.68 |
Late period |
0.95 ± 0.01 |
0.94 ± 0.03 |
1.02 ± 0.03 |
0.19 |
Plt (×103μl) |
||||
Preoperative |
25.7 ± 1.6 |
22.5 ± 1.3 |
25.3 ± 1.9 |
0.35 |
5 postoperative days |
19.7 ± 1.4 |
16.8 ± 1.3 |
16.8 ± 2.0 |
0.4 |
Early period |
25.7 ± 1.9 |
16.8 ± 1.3 |
26.6 ± 3.7 |
0.16 |
Late period |
22.1 ± 0.9 |
20.2 ± 2.9 |
19.4 ± 2.2 |
0.1 |
Alb (g/Dl) |
||||
Preoperative |
4.3 ± 0.1 |
4.0 ± 0.2 |
3.9 ± 0.2 |
0.22 |
5 postoperative days |
3.1 ± 0.1 |
3.1 ± 0.1 |
2.9 ± 0.1 |
0.55 |
Early period |
3.6 ± 0.2 |
3.5 ± 0.2 |
3.5 ± 0.2 |
0.74 |
Late period | 4.2 ± 0.1 | 3.9 ± 0.2 | 3.4 ± 0.3 | 0.003 |
p values* compare variables by the Kruskal-Wallis test among the three groups.